These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 35412016)

  • 41. Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention.
    Lange NF; Radu P; Dufour JF
    J Hepatol; 2021 Nov; 75(5):1217-1227. PubMed ID: 34339764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease.
    Ristic-Medic D; Bajerska J; Vucic V
    World J Gastroenterol; 2022 Jul; 28(27):3314-3333. PubMed ID: 36158263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians.
    Tayyem RF; Al-Dayyat HM; Rayyan YM
    Arab J Gastroenterol; 2019 Mar; 20(1):44-49. PubMed ID: 30872135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
    BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.
    Makri E; Goulas A; Polyzos SA
    Arch Med Res; 2021 Jan; 52(1):25-37. PubMed ID: 33334622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Adams LA; Anstee QM; Tilg H; Targher G
    Gut; 2017 Jun; 66(6):1138-1153. PubMed ID: 28314735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease.
    Powell EE; Wong VW; Rinella M
    Lancet; 2021 Jun; 397(10290):2212-2224. PubMed ID: 33894145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.
    Zelber-Sagi S; Salomone F; Mlynarsky L
    Liver Int; 2017 Jul; 37(7):936-949. PubMed ID: 28371239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence.
    Yabiku K
    Front Endocrinol (Lausanne); 2021; 12():768850. PubMed ID: 34950104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
    Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
    JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Salavatizadeh M; Soltanieh S; Ataei Kachouei A; Abdollahi Fallahi Z; Kord-Varkaneh H; Poustchi H; Mansour A; Khamseh ME; Alaei-Shahmiri F; Santos HO; Hekmatdoost A
    Front Endocrinol (Lausanne); 2023; 14():1228072. PubMed ID: 37674617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.
    Tziomalos K; Athyros VG; Karagiannis A
    Curr Vasc Pharmacol; 2012 Mar; 10(2):162-72. PubMed ID: 22239625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
    J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-alcoholic fatty liver disease; a full-bodied epidemic].
    Tushuizen ME; Holleboom AG; Koot BGP; Blokzijl H; van Mil SWC; Koek GH
    Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32267638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
    Firneisz G
    World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of diet in non-alcoholic fatty liver disease].
    Jun DW
    Korean J Gastroenterol; 2013 May; 61(5):243-51. PubMed ID: 23756665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diet and exercise in NAFLD/NASH: Beyond the obvious.
    Semmler G; Datz C; Reiberger T; Trauner M
    Liver Int; 2021 Oct; 41(10):2249-2268. PubMed ID: 34328248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.